STOCK TITAN

Abacus Global Management delays Q3 amid accounting review

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

Abacus Global Management, Inc. (ABX) said it will not file its Form 10-Q for the quarter ended September 30, 2026 by the extended deadline. It needs more time to review accounting for capital account credits provided to limited partners of certain private funds it advises, beginning in the second quarter of 2025, and transactions with related-party funds. The company will assess whether identified issues require corrections to prior periodic reports, potentially dating back to June 30, 2025, and reassess disclosure controls and internal control over financial reporting; the reassessment may conclude those controls were not effective.

Filing Explained

The notice adds that the review may significantly affect asset-management revenue and related-party items, including payables tied to limited-partner incentives; Abacus cannot estimate the changes to prior reports, including its November 5 earnings release.

Delayed 10-Q period ended September 30, 2026 Quarter covered by the delayed report
Potential prior-report review date June 30, 2025 Previously filed reports may be evaluated as far back as this date
capital account credits financial
"accounting for capital account credits provided to the limited partners"
limited partner incentives financial
"private funds’ limited partner incentives"
disclosure controls and procedures regulatory
"the Company’s disclosure controls and procedures"
Policies, routines and internal checks a public company uses to identify, collect and verify information that must appear in its financial reports and public filings, and to make sure that material news is disclosed accurately and on time. Investors care because effective controls increase confidence that the company’s reported numbers and disclosures are reliable and reduce the risk of surprises, much like a building’s inspection and alarm system helps occupants trust the structure’s safety.
internal control over financial reporting financial
"internal control over financial reporting"
Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is ABX’s September 2026 10-Q delayed?

ABX said it needs more time to evaluate accounting for capital account credits provided to limited partners of certain private funds it advises, beginning in the second quarter of 2025, and accounting for transactions between the company and its related-party funds.

Could ABX revise previously filed reports?

The company will evaluate the materiality of any identified issues to determine whether corrections are required in previously filed periodic reports, potentially dating back to June 30, 2025. It will also reassess disclosure controls and internal control over financial reporting.

Which financial items could change in ABX’s reports?

ABX said there may be significant changes in asset management revenue, related-party items and related-party payables associated with private-fund limited partner incentives. The company said it cannot yet estimate the extent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UNITED STATESOMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB Number:           3235-0058
Expires:           September 30, 2028
Estimated average burden
hours per response ............ 2.50
FORM 12b-25
SEC FILE NUMBER
001-39403
NOTIFICATION OF LATE FILING
CUSIP NUMBER
00258Y104
 


(Check one):
 Form 10-K
 Form 20-F
☐ Form 11-K
☒ Form 10-Q
 Form 10-D
 Form N-CEN
 Form N-CSR
For Period Ended:September 30, 2026
 Transition Report on Form 10-K
 Transition Report on Form 20-F
 Transition Report on Form 11-K
 Transition Report on Form 10-Q
For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION

Abacus Global Management, Inc.
Full Name of Registrant
N/A
Former Name if Applicable
333 South Garland Avenue, Suite 1500
Address of Principal Executive Office (Street and Number)
Orlando, FL 32801
City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a)The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;
(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Abacus Global Management, Inc. (the “Company” or “Registrant”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense and requires additional time to complete the preparation and review of its financial statements and related disclosures to be included in the Form 10-Q. The Company’s delay in timely filing its Form 10-Q is a result of its ongoing evaluation of the accounting for capital account credits provided to the limited partners of certain private funds advised by the Company starting in the second quarter of 2025, as well as the accounting associated with certain transactions between the Company and its related party funds. After the evaluation of the above items is completed, the Company will evaluate the materiality of any identified issues in the Company’s previously filed periodic reports, potentially dating back to June 30, 2025, to determine whether corrections are required. Additionally, the Company will need to perform a reassessment of its internal controls over financial reporting related to these items, which may result in a conclusion that the Company’s disclosure controls and procedures and internal control over financial reporting were not effective.





The Company intends to file the Form 10-Q as soon as practicable, but not within the extended filing date pursuant to Rule 12b-25.

Forward-Looking Statements. This notification contains forward-looking statements, including statements regarding the timing of the filing of the Form 10-Q. These statements are subject to risks and uncertainties, and may result in adjustments to the Company’s financial statements. The Company undertakes no obligation to update these forward-looking statements except as required by law.

PART IV — OTHER INFORMATION

(1)Name and telephone number of person to contact in regard to this notification
William McCauley
800561-4148
(Name)(Area Code)(Telephone Number)
(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
☒ Yes    o No
(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
☒Yes No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

When the Company completes the evaluation described above, there may be a significant change in asset management revenue, related party, and related party payables associated with the private funds’ limited partner incentives. At this time, due to the ongoing evaluation, the Company is unable to estimate the extent of any significant changes in previously filed reports, including the earnings release for the period ended September 30, 2026 filed on Form 8-K on November 5, 2026.


Abacus Global Management, Inc.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

DateNovember 17, 2026By/s/ William McCauley
Name:William McCauley
Title:Chief Financial Officer and Chief Operating Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).




Keep reading